Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Minimally invasive pancreatectomy with mesentericoportal venous resection: Results from a French national cohort.

HPB : the official journal of the International Hepato Pancreato Biliary Association·2026
Same author

Predicting Best Performers After Minimally Invasive Left Pancreatectomy: Insights From a National Cohort.

Annals of surgery·2026
Same author

ASO Visual Abstract: AFP Model Predicts Outcomes after Liver Resection: a Multicenter Retrospective Cohort Study.

Annals of surgical oncology·2026
Same author

AFP Model Predicts Outcomes After Liver Resection: A Multicenter Retrospective Cohort Study.

Annals of surgical oncology·2026
Same author

Adhesive hydrogel-enabled integrative fixation for cartilage and osteochondral repair.

Frontiers in bioengineering and biotechnology·2026
Same author

In Vitro Evaluation of an Adhesive Hydrogel-Based Chondrocyte Carrier for Enhanced Therapeutic Delivery.

Macromolecular bioscience·2026

Related Experiment Video

Updated: Jun 23, 2026

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma
05:22

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma

Published on: February 13, 2026

[Management of biliary tract carcinomas].

Catherine Delbaldo1, Alexis Laurent, Julien Grenier

  • 1Service d'oncologie médicale, université Paris-12, AP-HP, hôpital Henri-Mondor, 94000 Créteil. catherine.delbaldo@hmn.aphp.fr

La Revue Du Praticien
|May 26, 2009
PubMed
Summary

Biliary tract carcinomas, including gallbladder cancer and cholangiocarcinoma, are rare cancers with poor prognoses. While surgery offers the only cure, adjuvant and palliative treatments lack standardized protocols for advanced stages.

Related Experiment Videos

Last Updated: Jun 23, 2026

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma
05:22

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma

Published on: February 13, 2026

Area of Science:

  • Oncology
  • Gastroenterology

Context:

  • Biliary tract carcinomas (BTCs) represent rare malignancies, accounting for less than 5% of all cancers.
  • BTCs encompass gallbladder carcinoma and cholangiocarcinoma, originating from intrahepatic or extrahepatic bile ducts.
  • These cancers present a poor prognosis, with advanced disease yielding a median survival of only six months.

Purpose:

  • To summarize the current understanding and challenges in the management of biliary tract carcinomas.
  • To highlight the limited therapeutic options for advanced stages of these rare tumors.

Summary:

  • Surgical resection remains the sole potentially curative treatment for biliary tract carcinomas.
  • Adjuvant therapies like chemotherapy or radiotherapy may be considered post-surgery, but no standard approach is established.
  • Despite advancements in palliative chemotherapy, no definitive standard therapy exists for advanced biliary tract carcinomas.

Impact:

  • Underscores the critical need for novel therapeutic strategies and standardized treatment protocols for biliary tract carcinomas.
  • Emphasizes the poor survival rates and limited treatment efficacy for advanced stages, driving research for better interventions.